BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 31558876)

  • 1. Liver stiffness and serum markers for excluding high-risk varices in patients who do not meet Baveno VI criteria.
    Zhou H; Long J; Hu H; Tian CY; Lin SD
    World J Gastroenterol; 2019 Sep; 25(35):5323-5333. PubMed ID: 31558876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease.
    Colecchia A; Ravaioli F; Marasco G; Colli A; Dajti E; Di Biase AR; Bacchi Reggiani ML; Berzigotti A; Pinzani M; Festi D
    J Hepatol; 2018 Aug; 69(2):308-317. PubMed ID: 29729368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis.
    Petta S; Sebastiani G; Bugianesi E; Viganò M; Wong VW; Berzigotti A; Fracanzani AL; Anstee QM; Marra F; Barbara M; Calvaruso V; Cammà C; Di Marco V; Craxì A; de Ledinghen V
    J Hepatol; 2018 Oct; 69(4):878-885. PubMed ID: 29802949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the Baveno VI criteria to rule out high-risk varices using hepatic shear-wave elastography.
    Castro Filho ÉC; Fernandes FF; Villela-Nogueira C; Madeira E; Barros F; Luz R; Pereira GH; Perazzo H
    Eur J Gastroenterol Hepatol; 2023 May; 35(5):559-567. PubMed ID: 36966754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VariScreen secures the screening of high-risk varices in patients with hepatitis B virus-related cirrhosis beyond Baveno VI criteria.
    Tan M; Zhang W; Zhou H; Liu Y; Lu T; Zhang Y; Li C; Yang Y; Wu Y; Hu H; Li Y; Yang F; Lin S
    Front Physiol; 2022; 13():1006657. PubMed ID: 36237519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening varices in patients with HBV-related cirrhosis on antiviral therapy: Platelet alone or together with LSM.
    Wang B; Zhou J; Wu X; Sun Y; Li L; Li P; Li M; Jiang W; Xu M; Feng B; Xu X; Cheng J; Xie W; Han T; Wang X; Li H; Piao H; Wu S; Shi Y; Chen S; Kong Y; Ma H; Ou X; Jia J; You H
    Liver Int; 2021 Feb; 41(2):369-377. PubMed ID: 33277803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of biochemical parameters for non-invasive screening of oesophageal varices in comparison to elastography-based approach in patients with compensated advanced chronic liver disease.
    Pastrovic F; Madir A; Podrug K; Lucijanic M; Bokun T; Zelenika M; Mustapic S; Unic A; Derek L; Grgurevic I
    Biochem Med (Zagreb); 2022 Jun; 32(2):020712. PubMed ID: 35799983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baveno VI criteria and spleen stiffness measurement rule out high-risk varices in virally suppressed HBV-related cirrhosis.
    Wang H; Wen B; Chang X; Wu Q; Wen W; Zhou F; Guo Y; Ji Y; Gu Y; Lai Q; He Q; Li J; Chen J; Hou J
    J Hepatol; 2021 Mar; 74(3):584-592. PubMed ID: 33039403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baveno VII algorithm outperformed other models in ruling out high-risk varices in individuals with HBV-related cirrhosis.
    Zhang X; Song J; Zhang Y; Wen B; Dai L; Xi R; Wu Q; Li Y; Luo X; Lan X; He Q; Luo W; Lai Q; Ji Y; Zhou L; Qi T; Liu M; Zhou F; Wen W; Li H; Liu Z; Chen Y; Zhu Y; Li J; Huang J; Cheng X; Tu M; Hou J; Wang H; Chen J
    J Hepatol; 2023 Mar; 78(3):574-583. PubMed ID: 36356684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of high-risk esophageal varices in patients with compensated cirrhosis using albumin-bilirubin-platelet score.
    Abd Elbaser ES; Sharaf AL; Farag AA
    Eur J Gastroenterol Hepatol; 2022 Mar; 34(3):332-337. PubMed ID: 34402476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How can we enhance the performance of liver stiffness measurement using FibroScan in diagnosing liver cirrhosis in patients with chronic hepatitis B?
    Kim SU; Kim DY; Park JY; Lee JH; Ahn SH; Kim JK; Paik YH; Lee KS; Chon CY; Choi EH; Song KJ; Park YN; Han KH
    J Clin Gastroenterol; 2010 Jan; 44(1):66-71. PubMed ID: 19609218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of Baveno VI and Expanded-Baveno VI Criteria for predicting gastroesophageal varices in patients with alcoholic and non-alcoholic fatty liver disease.
    Pizzamiglio M; Weicker A; de Terwangne C; Henrion J; Descamps OS; De Vos M
    Acta Gastroenterol Belg; 2022; 85(2):321-329. PubMed ID: 35709776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of Esophageal Varices by Liver Stiffness and Platelets in Persons With Human Immunodeficiency Virus Infection and Compensated Advanced Chronic Liver Disease.
    Merchante N; Saroli Palumbo C; Mazzola G; Pineda JA; Téllez F; Rivero-Juárez A; Ríos-Villegas MJ; Maurice JB; Westbrook RH; Judge R; Guaraldi G; Schepis F; Perazzo H; Rockstroh J; Boesecke C; Klein MB; Cervo A; Ghali P; Wong P; Petta S; De Ledinghen V; Macías J; Sebastiani G
    Clin Infect Dis; 2020 Dec; 71(11):2810-2817. PubMed ID: 31813962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of three "beyond Baveno VI" criteria to safely spare endoscopies in compensated advanced chronic liver disease.
    Tosetti G; Primignani M; La Mura V; D'Ambrosio R; Degasperi E; Mezzina N; Viganò M; Rumi M; Fracanzani AL; Lombardi R; Fargion S; Fraquelli M; Aghemo A; Lampertico P
    Dig Liver Dis; 2019 Aug; 51(8):1135-1140. PubMed ID: 30691777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of FIB-4, aspartate aminotransferase-to-platelet ratio index and liver stiffness measurement in hepatitis B virus-infected patients with persistently normal alanine aminotransferase.
    Tan YW; Zhou XB; Ye Y; He C; Ge GH
    World J Gastroenterol; 2017 Aug; 23(31):5746-5754. PubMed ID: 28883700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of High-Risk Varices in Patients with Compensated Advanced Chronic Liver Disease in Saudi Arabia.
    Ismail M
    Clin Exp Gastroenterol; 2023; 16():117-127. PubMed ID: 37489180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of original, expanded Baveno VI, and stepwise & platelet-MELD criteria to rule out varices needing treatment in compensated cirrhosis from various etiologies.
    Nawalerspanya S; Sripongpun P; Chamroonkul N; Kongkamol C; Piratvisuth T
    Ann Hepatol; 2020; 19(2):209-213. PubMed ID: 31607647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A noninvasive indicator for the diagnosis of early hepatitis B virus-related liver fibrosis.
    Li B; Zhang L; Zhang Z; Yan G; Zhu L; Lu W; Yu H
    Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):218-223. PubMed ID: 30277926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver stiffness by two-dimensional shear wave elastography for screening high-risk varices in patients with compensated advanced chronic liver disease.
    Yan Y; Xing X; Wang X; Yang L
    Eur Radiol; 2022 Mar; 32(3):2078-2088. PubMed ID: 34713329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel liver stiffness measurement-based prediction model for cirrhosis in hepatitis B patients.
    Kim BK; Han KH; Park JY; Ahn SH; Chon CY; Kim JK; Paik YH; Lee KS; Park YN; Kim DY
    Liver Int; 2010 Aug; 30(7):1073-81. PubMed ID: 20492510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.